Clinical Trial Update: Symbicort in Chronic Obstructive Pulmonary Disease

View source ↗

Summary

The document reports the completion of a clinical trial evaluating Symbicort for Chronic Obstructive Pulmonary Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Status: COMPLETED